论文部分内容阅读
目的:探讨妈富隆治疗围绝经期子宫出血的临床疗效。方法:选取广汉市妇幼保健院收治的140例围绝经期子宫出血患者作为本次的研究对象,以患者自愿原则将所有研究对象分为观察组和对照组,每组70例。对照组采用米非司酮治疗,观察组采用妈富隆治疗,比较两组的治疗效果。结果:两组患者治疗总有效率比较,差异有统计学意义(P<0.05);且两组患者控制止血时间及完全止血时间比较,差异均有统计学意义(P<0.05)。结论:妈富隆治疗围绝经期子宫出血,可及早达到止血目的,临床应用价值较高。
Objective: To investigate Marvelon treatment of perimenopausal uterine bleeding in the clinical efficacy. Methods: One hundred and forty patients with perimenopausal uterine bleeding admitted to Guanghan MCH hospital were selected as the subjects of this study. All subjects were divided into observation group and control group according to the voluntary principle of patients, with 70 cases in each group. The control group was treated with mifepristone, the observation group was treated with Marvelon, and the treatment effect was compared between the two groups. Results: The total effective rate of the two groups was statistically significant (P <0.05). There was significant difference between the two groups in the control hemostasis time and complete hemostasis time (P <0.05). Conclusion: Marvelon treatment of perimenopausal uterine bleeding, as soon as possible to achieve the purpose of bleeding, clinical application of higher value.